January 26, 2022
Dr. Robert Califf has chance to bolster FDA’s credibility—regulate CBD
As Dr. Robert Califf’s nomination as FDA commissioner comes to the Senate for debate and approval, it is clear he has a tall order to fill. The COVID-19 pandemic has exposed FDA’s continuing challenge to restore public confidence in the aftermath of its opioid debacle.
Fortunately, there’s one area where Dr. Califf can take immediate action to bolster FDA’s credibility: directing the agency to finally regulate the growing hemp and CBD marketplace.
Click here to read the full op-ed piece from U.S. Hemp Roundtable General Counsel, Jonathan Miller from Natural Products Insider.
Help amplify the nationwide movement to #RegulateCBDnow today!